What makes SGLT2 inhibition so effective in lowering blood glucose in diabetes? (689.5)
Maria Gerasimova(VA San Diego Healthcare System), Volker Vallon(Unknown), Timo Rieg(University of South Florida), Michael Rose(VA San Diego Healthcare System), Takahiro Masuda(Jichi Medical University), Hermann Koepsell(University of Würzburg), Eric Mayoux(Boehringer Ingelheim (Germany)), Scott C. Thomson(UC San Diego Health System)
Cited by 1
Related Papers
Glucose transporters in brain in health and disease
|Pflügers Archiv - European Journal of Physiology|2020|520
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
|American Journal of Physiology-Renal Physiology|2013|481
Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5
|Journal of Clinical Investigation|2003|432
Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5
|Journal of Clinical Investigation|2003|404
Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia
|American Journal of Physiology-Renal Physiology|2013|308